Aspirin for the Heart: Go Uncoated
Taking low-dose aspirin daily has been touted for years to lower the risk of heart attack and stroke. Some people show resistance to this therapy in blood tests, but why?
An Aspirin a Day After Blood Clots
A common treatment after having a blood clot is taking blood thinner medication. But many doctors will eventually take patients off medication when it's no longer necessary. Then what?
Drug-Eluting PAD Stent Approved
US Food and Drug Administration officials have approved the first medication-coated stent designed to treat peripheral artery disease (PAD), giving patients with blocked thigh arteries another option.
When the Body Turns on Itself
Some people's immune systems produce antibodies that fight parts of their own bodies. These aren’t always a big deal. But sometimes they can contribute to stroke or miscarriage risk.
No Change in Change-of-Life Hormone Warnings
A decade ago, when a woman reached menopause, she likely reached for hormone replacement therapy to calm the symptoms associated with the change in life. Then a large study called the Women's Health Initiative challenged that treatment.
Newer Blood Thinner Gaining Affirmation
Patients with atrial fibrillation, a common heart arrhythmia, have a higher risk of experiencing a stroke or blood clots. Warfarin (Coumadin) has long been the gold standard in treatment. That could be changing.
Heart Diagnostic Test Recalled
A testing system commonly used to diagnose heart problems and other medical conditions has been recalled by the U.S. Food and Drug Administration.
Nano Clot-Buster Targets Blockage
Clot-busting drug tissue plasminogen activator ( tPA ) is the only approved treatment for dissolving blood clots common during stroke, heart attacks or pulmonary embolisms.
FDA Delays Blood Thinner Eliquis Again
United States Food and Drug Administration officials today delayed approval of Eliquis ( apixaban ) to prevent stroke or systemic embolism in patients with a common heart arrhythmia for the second time.
Experimental Drug Drops Clot Risk
An investigational drug appears to offer significant improvements for patients with peripheral artery disease (PAD), a recent trial found.